Linn, Wedén
Persson, Martina
Rathsman, Björn
Ludvigsson, Johnny
Lind, Marcus
Andersson Franko, Mikael
Nyström, Thomas
Funding for this research was provided by:
Barndiabetesfonden
Diabetesfonden
Hjärt-Lungfonden (20190298)
Karolinska Institute
Article History
Received: 25 November 2022
Accepted: 5 March 2023
First Online: 19 March 2023
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (Dnr 977-17).
: Not applicable.
: TN has received honoraria on expert group participation from AstraZeneca, Merck Sharp & Dohme, Novo Nordisk, Eli Lilly and Company, Boehringer Ingelheim, Abbot and Amgen. ML has received grants from Astra Zeneca, Dexcom, Novo Nordisk, and has been a consultant or received honoraria from Dexcom, Eli Lilly, Medtronic, Novo Nordisk and Rubin Medical. All other authors had nothing to disclose.